- ×îºóµÇ¼
- 2009-4-4
- ÔÚÏßʱ¼ä
- 1 Сʱ
- ¼ÄÍбÒ
- 175
- ÉùÍû
- 0
- ×¢²áʱ¼ä
- 2009-3-22
- ÔĶÁȨÏÞ
- 15
- Ìû×Ó
- 1
- ¾«»ª
- 2
- »ý·Ö
- 119
- UID
- 2619720
- ÉùÍû
- 0
- ¼ÄÍбÒ
- 175
- ×¢²áʱ¼ä
- 2009-3-22
- ¾«»ª
- 2
- Ìû×Ó
- 1
|
Ò»¡¢ ÃÀ¹úҩѧ:
ҩѧרҵÓйãÀ«µÄ¾Íҵǰ¾°, Òò´ËÊǺÜÈÈÃŵÄרҵ, ¾ºÕùºÜ¼¤ÁÒ. ҩѧרҵ, ²»½öÔÚÃÀ¹úµÄ¾ÍÒµÊг¡ºÜºÃ, ÔÚ¹úÄڵľÍҵǰ¾°Ò²ºÜ²»´í, ¶ÁҩѧרҵµÄѧÉú, ¿ÉÒÔÔÚÒ©Æ·¹«Ë¾, ÖÆÒ©³§, Ò½ÔºµÈ»ú¹¹¹¤×÷, ¶øÇÒнˮ¶¼ºÜ²»´í, ¾ÍÏñÊÇÄ¿Ç°ÔÚÃÀ¹úÊ®·Ö»ðÈȵÄÒ©¼Áʦ, ¸ù¾Ý2006ÄêµÄ¹Ù·½Í³¼Æ, ´ÓÒµÈËÊýΪ230,000ÈË61%µÄÒ©¼ÁʦÔÚÉçÇøÒ©·¿(ÀýÈ糬ÊлòÕ߶ÀÁ¢µÄÒ©µê)¹¤×÷¡£ ½ØÖÁ2004Äê5ÔµÄͳ¼Æ£¬Æ½¾ùÊÕÈë$84,900. ´Ó2004Ä꿪ʼ£¬ÃÀ¹úËùÓдóѧµÄҩѧԺȡÏûÕÐÊÕѧʿÏîĿѧÉú£¬ËùÓÐÃÀ¹ú´óѧµÄÒ©¼Áѧרҵ¸ÄΪ²©Ê¿Ñ§Î». ÔÚÃÀ¹úҩѧרҵ, Ö»ÓÐPHDÓëPharm D ²Å½ÏΪ±»³ÐÈÏ,ÓеÄѧУÉõÖÁ²»¿ªÉèMSѧλ.
PHDÓëPharm DÁ½Õß×î´óµÄÇø±ð, ÔÚÓÚPharm D ÊôÓÚprofessional training program, ¼¸ºõÊÇÍêÈ«×ԷѵÄ, ûÓн±Ñ§½ð, ÌرðÊǷDZ¾¹úµÄ¾ÓÃñѧ·Ñ¾Í¸ü¹óÁË, ¶ÔÖÝÄÚѧÉúÒ»ÄêµÄѧ·ÑÒª10000-20000£¬¶ø¶ÔÖÝÍâÒÔ¼°¹ú¼ÊѧÉú¸üÊÇÒª40000×óÓÒÒ»Äê(²¢²»°üÀ¨Éú»î·Ñ) ³ýÁË·ÑÓúܸßÖ®Íâ,ÉêÇëPharm DµÄÄѶÈÒ²Ï൱¸ß, Ò»ÊÇÒòΪËüÒª¿¼Ò©Ñ§Ôº¿¼ÊÔpcat(Pharmacy College Admissions Test), »¹ÐèÒªÓÐÔ¤¿Æ³É¼¨°üÀ¨ÃÀ¹úÀúÊ·£¬ÃÀ¹úÎÄѧµÈµÈµÄ, µ«²»¿ÉÒÔÓùúÄÚÐÞ¶ÁµÄ¹ýµÄ¿Î³Ì´úÌæ. ÊÂʵÉÏ, ²»ÊÇÿ¸öҩѧԺ¶¼»áÌṩPharm.D. degree, ÃÀ¹úÒ»¹²Ö»ÓÐ100Ëù×óÓÒAccreditation Council for Pharmacy Education (ACPE)ÈϿɵÄҩѧԺ(Ö»ÓÐACPEÈϿɵÄҩѧԺÊÚÓèµÄPharm.D. degree²Å¿ÉÒÔÉêÇëµ±pharmacist) ¶þÊǶÔÓÚ±¾ÍÁѧÉúµÄ±£»¤Õþ²ß, ¶ÔÓÚ¿ª·Å¸ø¹ú¼ÊѧÉúµÄ»ú»á½ÏÉÙ, ÿ¸öÖݵÄҩѧԺPham.D.program ÿÄêÕÐÉú¶¼ÓÐÒ»¶¨µÄ±ÈÀý¹æ¶¨±ØÐëÕкܶàÖÝÄÚµÄѧÉú£¬Õâ¸ö±ÈÀý´óÓÚ70%¡£Êµ¼ÊÇé¿ö±ÈÕâ¸ö»¹Òª¶à.µ«ÊÇ, »¹ÊÇÓÐһЩ±³¾°ºÜÇ¿µÄÈË¿ÉÒԳɹ¦ÉêÇëµ½Pharm DµÄ. Ê×ÏÈËûÃÇҪͨ¹ýForeign Pharmacy Graduate Examination Committee (FPGEC)ÈÏÖ¤£¬È»ºóͨ¹ýForeign Pharmacy Graduate Equivalency Examination (FPGEE)£¬TOEFLºÍTSE¿¼ÊÔ¡£×îºóҪͨ¹ýNAPLEXºÍMJPEÖ´Òµ¿¼ÊÔ£¬¾Í¿ÉÒÔ³ÉΪҩ¼Áʦ.ÒòΪҩѧרҵµÄ¹¤×÷Óб£ÕÏ£¬±¨³êÓÖÓźñ£¬¾ºÕùÒì³£¼¤ÁÒ, ¼´Ê¹ÊÇÃÀ¹úµÄѧÉú¶¼²»ÈÝÒ×ÉêÇë, ¾ÍÏñÊÇUFL, 2000¸öÈ˾ºÕù300¸öλÖÃ.
¶þ¡¢ ·½ÏòÓë¼ȡ:
ÃÀ¹ú¿ªÉèÓÐҩѧԺµÄѧУÓкܶà,´ÓҩѧרҵÀï¸÷¸ö·ÖÖ§µÄ¼ȡoffer°ñÖÐ, ¾ÓÓÚÊ×λµÄÊÇÖÆҩѧ, Æä´ÎÊÇÒ©Àíѧ, ÔÙÕß¾ÍÊÇÒ©¼Áѧ.
1 ÖÆҩѧ
ÖÆҩѧPharmaceuticsÊÇÒ»ÃÅΪÁÙ´²ºÏÀíÓÃÒ©·ÀÖμ²²¡Ìṩ»ù±¾ÀíÂÛµÄҽѧ»ù´¡Ñ§¿Æ£¬ËüÉæ¼°Ò©Æ·Ñз¢¡¢ÖÆÔì¼°ÆäÅäÖƺÍÖü´æ£¬ÒÔ¼°Ò©Æ·ÌØÕ÷¡¢´¿¶È¡¢³É·ÖºÍ¹¦Ð§µÄ¼ì²â¡£ ϸ·ÖΪ(i)Ò©Îï´úл¶¯Á¦Ñ§ pharmacokinetics/ÉúÎïÖÆҩѧ biopharmaceutics, (ii) pharmaceutical analysis Ò©Îï·ÖÎö (iii) Ò©ÎïÉúÎï¼¼ÊõºÍÒ©Îï´«µÝ pharmaceutical biotechnology and drug delivery.
University of North Carolina at Chapel Hill
±±¿¨ÂÞÀ´ÄÉÖÝ´óѧ½ÌÌÃɽ·ÖУ£¨university of north carolina at chapel hill£©Î»ÓÚ±±¿¨ÂÞÀ´ÄÉÖݽÌÌÃɽ£¬¼ò³Æunc£¬³ÉÁ¢ÓÚ1789Ä꣬ÊÇÈ«ÃÀ×îÔçµÄÖÝÁ¢´óѧ£¬ÔÚ18ÊÀ¼Íʱ£¬ËüÊÇÈ«ÃÀΨһÊÚÓèѧλµÄ¹«Á¢´óѧ¡£Æä½ÌÓýˮƽ£¬Ñо¿³É¾Í£¬¹ú¼ÊÃûÉù£¬Ð£Ô°½¨ÉèµÈ¸÷·½Ã棬¶¼ÊÇ×îÇ¿µÄ£¬ÓµÓÐÔÚУѧÉúÁ½ÍòÆßǧ¶àÈË£¬½Ìʦһǧ¶àÃû£¬ÉúÔ´Á¼ºÃ.ÓÉÓڵصãλÖÃÒÔ¼°Ñ§ÊõÁ¦Á¿ºÜÇ¿, Ò»Ö±¶¼ÉîÊܹúÄÚµÄÅ£ÈË»¶Ó. UNCµÄÖÆҩѧ, Æ«ÏòÓÚ·Ö×ÓµÄÑо¿, ´Óµ°°×ÖÊ, ÒÅ´«Òò×Ó, ÒßÃçµÈ½Ç¶È·ÖÎöÒ©ÎïµÄÊäËÍÒÔ¼°¶ÔÈËÀàµÄÓ°Ïì. UNCµÄҩѧԺϵºÜ´ó, ÓÐ22¸ö½ÌÊÚ, 6¸öÒ©ÎïÑо¿ÖÐÐÄ, ¸ÃУûÓÐÌṩMSѧλ, Ö»ÓÐPHDÒÔ¼°Pharm D.
Uni. of Texas-Austin
µÃ¿ËÈø˹´óѧ°Â˹͡·ÖУ(University of Texas at Austin)ÊǵÿËÈø˹´óѧµÄÖ÷У£¬Ò²ÊÇÃÀ¹ú×î´óµÄ´óѧ£¬Ê¼½¨ÓÚ1883Äê. Èç½ñÕ¼µØ350ӢĶ£¬ÓнÌʦ2700Ãû£¬49000ÃûÔÚУѧÉúÀ´×ÔÃÀ¹ú50¸öÖݺÍÈ«ÊÀ½ç100¶à¸ö¹ú¼Ò£¬ÓÈÆäÖµµÃÒ»ÌáµÄÊÇ£¬¸ÃУ»ñµÃµÄ¾¼Ã×ÊÖúºÍ¾è¿î½ö´ÎÓÚ¹þ·÷´óѧ£¬ÐÛºñµÄ¾¼ÃʵÁ¦±£Ö¤ÁËʦ×ʵÄÖÊÁ¿. µ«ÊÇÓëUNCÏà±È½Ï, Uni. of Texas-AustinµÄÖÆҩѧϵ¾ÍСºÜ¶àÁË, ÓÐ7λ½ÌÊÚ, µ«ÊÇУÄÚµÄÑо¿ÖÐÐÄÓÐ10¸ö, ʵ¼ù»ú»á»¹ÊǺܶàµÄ, ÕâËùѧУÓÐÌṩµ½MSѧλ.
2 Ò©Àíѧ
Ò©ÀíѧpharmacologyÑо¿µÄÖ÷Òª¶ÔÏóÊÇ»úÌ壨°üÀ¨²¡ÔÌ壩Ï໥×÷ÓõĹæÂɼ°ÆäÔÀí, ÊôÓÚ¹ãÒåµÄÉúÀí¿Æѧ·¶³ë, Ò©ÀíѧÊÇҽѧ½ÌÓýÖеÄÒ»ÃÅ»ù´¡ÓëÁÙ´²µÄÇÅÁºÑ§¿Æ£¬ËüÒÔ»ù´¡Ñ§¿ÆΪ»ù´¡£¨ÈçÉúÀíѧ¡¢ÉúÎﻯѧ¡¢²¡ÀíѧµÈ£©À´²ûÃ÷ÆäÒ©ÎïµÄÒ©Àí×÷ÓúÍ×÷ÓûúÖÆ£¬ÎªÁÙ´²ºÏÀíÓÃÒ©·ÀÖμ²²¡µì¶¨ÀíÂÛ»ù´¡¡£Ò©Àíѧһ·½ÃæÑо¿ÔÚÒ©ÎïÓ°ÏìÏ»úÌåϸ°û¹¦ÄÜÈçºÎ·¢Éú±ä»¯£¬Ò©ÎïЧӦ¶¯Á¦Ñ§£¨pharmacodynamics£©£¬¼ò³ÆҩЧѧ. ÁíÒ»·½ÃæÑо¿Ò©Îï±¾ÉíÔÚÌåÄڵĹý³Ì£¬¼´»úÌåÈçºÎ¶ÔÒ©Îï½øÐд¦Àí£¬³ÆΪҩÎï´úл¶¯Á¦Ñ§(pharmacokinetics)£¬¼ò³ÆÒ©¶¯Ñ§¡£´ÓÉÏÃæµÄ½éÉÜÖÐ, ¿ÉÒÔÖªµÀÁËÒ©Àíѧ·½ÏòµÄÑо¿, ÊÇ»ù´¡Ñо¿ÓëÁÙ´²µÄÁ¬½Ó¿Ú, ѧϰ¸Ãרҵ, ¼ÈÒª¶Ôҩѧ²»¶Ï½øÐÐÑо¿, »¹ÐèÒª¶Ô²¡ÀíµÄÈÏʶ³Ì¶È²»¶ÏÉ, Èç¹ûÑ¡ÔñÁËÒ©Àíѧ, ÒÔºóÎÞÂÛÊÇÒª¼ÌÐø´ÓÊ»ù´¡Ñо¿, »¹ÊÇרÏòÁÙ´²·½Ïò, ¶¼±È½ÏÓÐÀû, ¶øÇÒÉêÇëµÄÄѶÈ, ûÓÐÖÆÒ©·½ÏòÄÇô¸ß. ¶øÇÒÑ¡ÔñÒ©ÀíѧµÄÈËÒ²ÊDz»ÉÙµÄ,
Cornell
¿µÄζû´óѧ£¨Cornell University£©ÊÇÓÉÆóÒµ¼Ò°£×ÈÀ•¿µÄζûºÍѧÕß°²µÂ³•»³ÌØÁ½ÈËЯÊÖºÏ×÷´´°ìµÄÒ»Ëù¶À¾ßÌØÉ«µÄ´óѧ£¬Ëü³ÉÁ¢ÓÚ1865Äê, ͼÊé¹ÝϵȫÃÀÊ®´óͼÊé¹ÝÖ®Ò»£¬ÓµÓÐ600¶àÍò²áÊé¼®¼°6Íò¶à±¾ÆÚ¿¯, ÕæµÄÊÇѧϰʥµØ, ¸ÃУµÄÖÆҩרҵҲÏ൱ÓйæÄ£, ÓÐ28¸ö½ÌÊÚÔÚ´ÓÊÂÖÆÒ©Ñо¿, ÆäÖаüÀ¨ÁËÒ©ÎïÉñ¾Ñ§, ¶¾Îïѧ, »ùÒò×éѧµÈµÈ.
Kansas U
¿°Èø˹´óѧ½¨ÓÚ1866Ä꣬ÊÇÒ»Ëù×ÛºÏÐԵĽÌѧÓëÑо¿²¢ÖصĴóѧ¡£´óѧÉèÓÐ170¶à¸öרҵÁìÓòµÄѧλ£¬Ä¿Ç°×ܹ²ÓÐ2100¶àÃû½Ìʦ£¬29272ÃûѧÉú£¬ÆäÖаüÀ¨À´×ÔÊÀ½ç100¶à¸ö¹ú¼ÒµÄ1600Ãû¹ú¼ÊѧÉú, ¿É¼û¸ÃУ¶ÔÓÚ¹ú¼ÊѧÉú»¹ÊÇÆÄΪ½ÓÊܵÄ, ¸ÃѧУµÄÒ©ÀíѧÓ붾Îïѧ²¢ÔÚͬһ¸öϵÀïÃæ, ¶øÕû¸öϵµÄ½ÌÊÚÒ²Ö»ÓÐ11ÈË, ¸ÃУµÄÒ©Àíרҵ, ±È½Ï¼¯ÖÐÔÚÉñ¾Ò©Àíѧ, ´ÓÈ˵ÄÉñ¾ÏµÍ³ÒÔ¼°ÇéÐ÷µÄ½Ç¶È·ÖÎöÒ©Àí, µ«ÊÇ´ÓѧУµÄÑо¿×ÊÔ´ÉÏ¿´, 11¸öÒ©ÎïÑо¿ÖÐÐÄÒ²»¹ÊÇÏ൱ÓпÆÑÐʵÁ¦µÄÒ»ËùѧУ.
3 Ò©¼Áѧ
University of Washington
Î÷ÑÅͼ»ªÊ¢¶Ù´óѧ(University Of Washington, Seattle)λÓÚÃÀ¹ú»ªÊ¢¶ÙÖݵÄÎ÷ÑÅͼ£¬ÊÇÒ»Ëù½¨ÓÚ1861ÄêµÄ¹«Á¢Ñо¿ÐÍ´óѧ£¬Ò²ÊÇÃÀ¹úÎ÷°¶ÀúÊ·×îÓƾõĹ«Á¢´óѧ¡£Ñо¿ÏµËùÖÐÿÄê¿ÉÒÔÅàÑø³öÒ»Íò¶àÃûרҵÑо¿Éú£¬´óԼռȫУѧÉúÈËÊýµÄ25%×óÓÒ¡£ÔÚÕâЩÑо¿ÉúÖУ¬´ó¸ÅÓÖÓÐ15%Êô¹ú¼ÊѧÉú. ¸ÃУµÄÒ©¼ÁרҵÓÐ12¸ö½ÌÊÚ¼°5¸ö¸±½ÌÊÚ, ÔÚҩѧרҵÀïÃæ, ³ýÁËÉèÖÃÓÐרÃÅÑо¿Ò©ÎïµÄÑо¿ÖÐÐÄÖ®Íâ, Ò²ÓÐÕë¶Ô°¬×̲¡ÒÔ¼°°©Ö¢¼²²¡µÄÒ©ÎïÑо¿.
UIC
ÒÁÀûŵ´óѧʼ½¨ÓÚ1867 Ä꣬ÊÇÃÀ¹úÊ®Ëù×î´óµÄÖÝÁ¢´óѧ֮һ. Ò²ÊÇÖ¥¼Ó¸çµØÇø×î´óµÄÒ»Ëù½áºÏ½Ìѧ¡¢¿ÆÑкͿª·¢ÎªÒ»ÌåµÄ×ÛºÏÐԸߵȽÌÓýԺУ, ±»ÓþΪ¡°Åµ±´¶û½±¡±»ñµÃÕßµÄÒ¡Àº£¬ÔøÏȺóÅàÓý³öŵ±´¶û½±»ñµÃÕß30¶àÈË. ÔÚҩѧԺÀïÓÐ10¸öÒ©ÎïÑо¿ÏîÄ¿, ÆäÖиüÊÇ°üÀ¨ÁËNIHÒÔ¼°WHOµÄ×ÊÖúÑо¿, Òò´Ë¿ÆÑÐʵÁ¦·Çͬһ°ã.
ÒÔÏÂÊÇҩѧµÄÆäËü·½ÏòµÄ½éÉÜ:
Ò©ÎﻯѧMedicinal Chemistry: ´Ó»¯Ñ§ÔÀíÒÔ¼°ÉúÎïÔÀí·½Ãæ, Ñо¿Ò©ÎïµÄÉè¼ÆÒÔ¼°Ò©ÎïµÄ·¢Õ¹£¬Ò©ÎïµÄ»¯Ñ§ºÏ³ÉÓëÉúÎïѧµÄ»ù±¾ÀíÂÛ֪ʶºÍʵ¼ù¼¼ÄÜ, Ñо¿µÄÄÚÈÝÓÐdrug discovery, organic synthesis of medicinal agents, natural products chemistry, prodrugs, topical drug delivery, peptide chemistry, molecular modeling, drug metabolism and molecular toxicology.ÔÚ¸ÃÁìÓòµÄ½ÌÊÚÃǵÄÑо¿»á¼¯ÖÐÔÚ·Ö×Ó»úÖÆ, ϸ°û, ø, µ°°×ÖʵȽǶÈÑо¿Ò©µÄ×÷ÓÃ. ¸Ã·½ÏòµÄÉêÇëÒªÇó, ±È½Ï×¢ÖØÉêÇëÕߵĻ¯Ñ§±³¾°, ÀýÈç·ÖÎö»¯Ñ§, ÎÞ»ú»¯Ñ§µÄ±³¾°, Èç¹ûÑо¿ÐËȤ±È½ÏÆ«Ïò»¯Ñ§, ¿ÉÒÔ¿¼ÂÇÉêÇë¸Ã·½Ïò.
Ò©ÎïÕþ²ßPharmaceutical Outcomes and Policy: Ö¸Ò©ÎïÖÎÁƶÔÎÀÉú±£½¡ÏµÍ³ºÍÈËÀàÉç»áËù¸¶³öµÄ³É±¾ºÍ²úÉúЧ¹ûµÄÃèÊöºÍ·ÖÎö¡£¾ßÌåµØ˵£¬Ò©Îï¾¼ÃѧӦÓÃÏÖ´ú¾¼ÃѧµÄÑо¿ÊֶΣ¬½áºÏÁ÷Ðв¡Ñ§¡¢¾ö²ßѧ¡¢ÉúÎïͳ¼ÆѧµÈ¶àѧ¿ÆÑо¿³É¹û£¬È«·½Î»µØ·ÖÎö²»Í¬Ò©ÎïÖÎÁÆ·½°¸¡¢Ò©ÎïÖÎÁÆ·½°¸ÓëÆäËü·½°¸£¬ÈçÊÖÊõÖÎÁÆÒÔ¼°²»Í¬Ò½ÁÆ»òÉç»á·þÎñÏîÄ¿£¬ÈçÉç»áÑøÀÏÓë¼ÒÍ¥Õչ˵ȵijɱ¾¡¢Ð§Òæ»òЧ¹û¼°Ð§Óã¬ÆÀ¼ÛÆä¾¼Ãѧ¼ÛÖµµÄ²î±ð¡£Ò©Îï¾¼ÃѧµÄ·þÎñ¶ÔÏó°üÀ¨Ò½ÁƱ£½¡ÌåϵµÄËùÓвÎÓëÕߣºÕþ¸®¹ÜÀí²¿ÃÅ¡¢Ò½ÁÆÌṩµ¥Î»¡¢Ò½ÁƱ£ÏÕ¹«Ë¾¡¢Ò½ÉúÒÔ¼°²¡ÈË¡£Ò©Îï¾¼ÃѧĿǰÒÑ·¢Õ¹³ÉΪһÃÅÐÂÐ˵ıßԵѧ¿Æ£¬Êܵ½Ô½À´Ô½¶àµÄÑо¿ÕßµÄÖØÊÓ¡£
Ò©Îï¾Óª/¹ÜÀípharmacy administration: ×ÛºÏҩѧ¡¢·¨Ñ§¡¢¹ÜÀíѧ¡¢¾¼Ãѧ¡¢Éç»áѧ¼¸ÃÅѧ¿ÆµÄ֪ʶ, ÊÇһλ²æµÄѧ¿Æ, ÒªÇ󶮵ôÓÒ©·¿µÄ¹ÜÀí,Ò©Æ·µÄÖÊÁ¿, Ò©·½µÄ´¦Àí, Ò©Æ·µÄÏúÊÛÒÔ¼°¼à¶½µÈ·½ÃæµÄÓ¦ÓÃÄÜÁ¦.Ò©ÎïÕþ²ßÒÔ¼°Ò©Îï¹ÜÀí, ¶¼ÊǽÏΪƫÏò¹ÜÀí·½ÃæµÄ, ÊôÓÚÓ¦ÓÃÐÍ,Òò´ËÔÚÕâ¸ö·½ÏòÏÂ×öʵÑéÑо¿µÄ»ú»áÉÙ, »ñµÃ½±Ñ§½ðµÄ»ú»áÒ²½ÏÉÙÁË.Ä¿Ç°ÉêÇëҩѧרҵ²¢ÇÒÄõ½OfferµÄ, ¶¼ÊÇÆ«ÏòʵÑéÑо¿µÄ, ÉêÇëÒ©Îï¹ÜÀí»òÕßÒ©Îᄐ÷½ÏòµÄÈËËùÕ¼µÄ±ÈÀý»¹ÊÇÆ«ÏòÉÙÊý, µ«ÊÇÄÇЩÁãÐǵÄÒ©Îï¾¼ÃѧµÄofferÒ²ÊÇ˵Ã÷ÁËͬÑùÓÐÉê½±³É¹¦µÄ¿ÉÄܵÄ. |
|